Product Name :
Anti-IL23A(Brazikumab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human IL23A
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-IL23A(Brazikumab Biosimilar) Antibody is a biosimilar antibody directed against Human IL23A. | Isotype: Human IgG2 | Conjugate: Unconjugated | Specificity: Human IL23A | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-IL23A(Brazikumab Biosimilar) Antibody is a biosimilar antibody directed against Human IL23A.
Immunogen:
Host :
Isotype:
Human IgG2
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.{{1703778-92-0} web|{1703778-92-0} Protocol|{1703778-92-0} Purity|{1703778-92-0} custom synthesis} Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc.{{113-73-5} MedChemExpress|{113-73-5} Purity & Documentation|{113-73-5} Description|{113-73-5} manufacturer} The actual dilution used must be determined empirically.PMID:31424743
